M
Markus Höltje
Researcher at Humboldt University of Berlin
Publications - 48
Citations - 2886
Markus Höltje is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Synaptic vesicle & Vimentin. The author has an hindex of 25, co-authored 46 publications receiving 2480 citations. Previous affiliations of Markus Höltje include Technische Universität München & Charité.
Papers
More filters
Journal ArticleDOI
Serotonylation of small GTPases is a signal transduction pathway that triggers platelet α-granule release
Diego J. Walther,Jens-Uwe Peter,Sandra Winter,Markus Höltje,Nils Paulmann,Maik Grohmann,Jakob Vowinckel,Victor Alamo-Bethencourt,Claudia S. Wilhelm,Gudrun Ahnert-Hilger,Michael Bader +10 more
TL;DR: It is shown that mice selectively deficient in peripheral TPH and serotonin exhibit impaired hemostasis, resulting in a reduced risk of thrombosis and thromboembolism, although the ultrastructure of the platelets is not affected.
Journal ArticleDOI
N-Methyl-d-Aspartate Receptor Antibodies in Herpes Simplex Encephalitis
Harald Prüss,Carsten Finke,Markus Höltje,Joerg Hofmann,Christine Klingbeil,Christian Probst,Kathrin Borowski,Gudrun Ahnert-Hilger,Lutz Harms,Jan M. Schwab,Christoph J. Ploner,Lars Komorowski,Winfried Stoecker,Josep Dalmau,Josep Dalmau,Klaus-Peter Wandinger +15 more
TL;DR: To determine the presence and kinetics of antibodies against synaptic proteins in patients with herpes simplex virus encephalitis, a large number of patients with HSE are treated with antiretroviral medication.
Journal ArticleDOI
Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin.
Harald Prüss,Josep Dalmau,Lutz Harms,Markus Höltje,Gudrun Ahnert-Hilger,Kathrin Borowski,Winfried Stoecker,Klaus-Peter Wandinger +7 more
TL;DR: Six of 7 cases with the indicated clinical criteria had anti-NMDAR encephalitis, which represented 1% of all young patients' admissions to the ICU, and NMDAR antibodies should be tested in all patients withEncephalitis who fulfill these criteria.
Journal ArticleDOI
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
Jakob Kreye,S. Momsen Reincke,Hans Christian Kornau,Hans Christian Kornau,Elisa Sanchez-Sendin,Elisa Sanchez-Sendin,Elisa Sanchez-Sendin,Victor M. Corman,Hejun Liu,Meng Yuan,Nicholas C. Wu,Xueyong Zhu,Chang-Chun D Lee,Jakob Trimpert,Markus Höltje,Kristina Dietert,Laura Stöffler,Laura Stöffler,Niels von Wardenburg,Niels von Wardenburg,Scott van Hoof,Scott van Hoof,Scott van Hoof,Marie A Homeyer,Marie A Homeyer,Julius Hoffmann,Julius Hoffmann,Azza Abdelgawad,Achim D. Gruber,Luca D. Bertzbach,Daria Vladimirova,Lucie Y Li,Lucie Y Li,Paula Charlotte Barthel,Karl Skriner,Andreas C. Hocke,Stefan Hippenstiel,Martin Witzenrath,Norbert Suttorp,Florian Kurth,Florian Kurth,Christiana Franke,Matthias Endres,Dietmar Schmitz,Dietmar Schmitz,Lara Maria Jeworowski,Anja Richter,Marie Luisa Schmidt,Tatjana Schwarz,Marcel A. Müller,Christian Drosten,Daniel Wendisch,Leif E. Sander,Nikolaus Osterrieder,Nikolaus Osterrieder,Ian A. Wilson,Harald Prüss,Harald Prüss,Harald Prüss +58 more
TL;DR: Results show that non-self-reactive virus-neutralizing mAbs elicited during SARS-CoV-2 infection are a promising therapeutic strategy and should be guided by immunization strategies.
Journal ArticleDOI
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment
Harald Prüss,Markus Höltje,Nikolaus Maier,A. Gomez,Ralph Buchert,Lutz Harms,Gudrun Ahnert-Hilger,Dietmar Schmitz,C. Terborg,Ute A. Kopp,Christine Klingbeil,Christian Probst,Siegfried Kohler,Jan M. Schwab,Winfried Stoecker,Josep Dalmau,Klaus-Peter Wandinger +16 more
TL;DR: A subset of patients with slowly progressive cognitive impairment has an underlying synaptic autoimmunity that decreases the density of NMDAR and other synaptic proteins, and alters synaptic currents, and can be demonstrated examining patients' serum and CSF for N MDAR IgA antibodies, identifying possible candidates for immunotherapy.